ILMN
Illumina, Inc. · Healthcare · Medical - Diagnostics & Research
动量输入(同类管理人): 持有人广度 0.0% · 股份流向 +30.0% · 净新建仓位 0.0% — 公式
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q4 2024
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 164 | +8 | 117.28M | $20.61B | +11 | −2 |
| Q1 2026 | 158 | -5 | 113.90M | $14.03B | +5 | −11 |
| Q4 2025 | 162 | 0 | 124.91M | $16.38B | +2 | −1 |
| Q3 2025 | 23 | -1 | 78.13M | $7.41B | +1 | −3 |
| Q2 2025 | 22 | 0 | 71.58M | $6.83B | +1 | −1 |
| Q1 2025 | 19 | 0 | 39.00M | $3.09B | +1 | −1 |
| Q4 2024 | 19 | 0 | 37.37M | $4.99B | +2 | −2 |
| Q3 2024 | 18 | 0 | 20.75M | $2.70B | +1 | −1 |
| Q2 2024 | 18 | — | 22.19M | $2.32B | — | — |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 18.03M | +408.6% | $2.41B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (被动) | 5.79M | — | $774.19M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 3.02M | -16.7% | $403.32M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 3.02M | -16.7% | $403.32M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 3.02M | -16.7% | $403.32M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 3.02M | -16.7% | $403.32M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (被动) | 2.73M | +0.2% | $364.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Geode Capital Management ✦ (被动) | 2.73M | +0.2% | $364.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | PRIMECAP Management ✦ | 2.46M | -2.4% | $328.17M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 10 | Norges Bank ✦ (被动) | 1.71M | -12.1% | $228.71M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 904.86K | -16.5% | $120.92M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 733.92K | -34.1% | $98.07M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 13 | ARK Investment Management ✦ | 686.33K | 新增 | $91.71M | 0.8% | New | 1 | SEC ↗ |
| 14 | Millennium Management ✦ | 531.49K | -63.7% | $71.02M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 459.49K | -28.8% | $61.40M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 459.49K | -28.8% | $61.40M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 459.49K | -28.8% | $61.40M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 459.49K | -28.8% | $61.40M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 459.49K | -28.8% | $61.40M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 108.35K | -3.3% | $14.48M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 108.35K | -3.3% | $14.48M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Arrowstreet Capital ✦ | 67.52K | 新增 | $9.02M | 0.0% | New | 1 | SEC ↗ |
| 23 | Icahn Capital ✦ | 40.00K | -90.7% | $5.35M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 34.94K | +5.4% | $4.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 34.94K | +5.4% | $4.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 26.92K | -37.3% | $3.60M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 27 | Wellington Management ✦ | 25.30K | -18.2% | $3.38M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 28 | Wellington Management ✦ | 25.30K | -18.2% | $3.38M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 8.44K | -46.7% | $1.13M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 30 | GAMCO Investors ✦ | 1.58K | -18.3% | $211,804 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| ARK Investment Management | $91.71M | 0.8% |
| Arrowstreet Capital | $9.02M | 0.0% |
已清仓
| Marshall Wace | $161.68M | 曾为 0.2% |
| Soros Fund Management | $22.82M | 曾为 0.6% |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 837 持有人, 154.80M 股份, $18.58B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Director · 8.19K 股 · $1.78M
Director · 86.83K 股 · $18.98M
Director · 133.26K 股 · $29.25M
Director · 3.88K 股 · $854,765
Director · 4.53K 股 · $952,918
Director · 7.15K 股 · $1.51M
Director · 13.05K 股 · $2.78M
Director · 6.82K 股 · $1.46M
Director · 13.67K 股 · $2.93M
Director · 9.37K 股 · $2.02M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论